FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118541844> ?p ?o ?g. }

• W3118541844 endingPage "587" @default.
• W3118541844 startingPage "575" @default.
• W3118541844 abstract "Synthetic cathinones appeared on the market in the 2000s as new psychoactive substances and gained significant prevalence among drug abusers. Cathinones produce psychostimulant and empathogenic effects by enhancing dopaminergic, noradrenergic, and serotoninergic neurotransmission in the brain, and those which potently and selectively enhance dopaminergic transmission are considered to have higher abuse potential. The present study examines the behavioral effects related to psychostimulant properties, abuse potential, and addiction in DBA/2J mice of two cathinones with different profile of action on monoamine system, 4-chloromethcathinone (4-CMC), and 4-methoxy-pyrrolidinopentiophenone (4-MeO-PVP). 4-CMC and 4-MeO-PVP increase spontaneous locomotor activity after acute treatment and produce behavioral sensitization after 7-day intermittent treatment, which is a common feature of drugs of abuse. 4-MeO-PVP, but not 4-CMC, produces conditioned place preference after 4 days, indicating its rewarding properties. Finally, the ability of 4-CMC and 4-MeO-PVP to induce withdrawal symptoms after discontinuation from 14-day treatment was assessed using a battery of tests for behavioral markers of depression in mice: a tail suspension test, a forced swim test, measuring despair, and a sucrose preference test, measuring anhedonia. None of the three tests revealed increased depressive symptoms. Moreover, neither spontaneous locomotor activity nor motor performance on a rotarod was impaired after 14-day treatment with the tested compounds. These results indicate that 14-day treatment of mice with 4-CMC or 4-MeO-PVP does not induce significant withdrawal symptoms after cessation, nor significant impairment of dopaminergic circuitry resulting in motor impairment. The current study shows that 4-CMC and 4-MeO-PVP produce abuse-related behavioral changes in mice, which are more pronounced after more dopamine-selective 4-MeO-PVP." @default.
• W3118541844 created "2021-01-18" @default.
• W3118541844 creator A5038460349 @default.
• W3118541844 creator A5061448417 @default.
• W3118541844 creator A5069959118 @default.
• W3118541844 date "2021-01-11" @default.
• W3118541844 modified "2023-09-25" @default.
• W3118541844 title "Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment" @default.
• W3118541844 cites W1576947987 @default.
• W3118541844 cites W1914747759 @default.
• W3118541844 cites W1971712976 @default.
• W3118541844 cites W1979149627 @default.
• W3118541844 cites W1995588094 @default.
• W3118541844 cites W2015881796 @default.
• W3118541844 cites W2017404713 @default.
• W3118541844 cites W2022189889 @default.
• W3118541844 cites W2024861481 @default.
• W3118541844 cites W2028940888 @default.
• W3118541844 cites W2058003924 @default.
• W3118541844 cites W2062123657 @default.
• W3118541844 cites W2064654883 @default.
• W3118541844 cites W2067240690 @default.
• W3118541844 cites W2071513980 @default.
• W3118541844 cites W2071591702 @default.
• W3118541844 cites W2105222863 @default.
• W3118541844 cites W2107373266 @default.
• W3118541844 cites W2120610043 @default.
• W3118541844 cites W2155709733 @default.
• W3118541844 cites W2170871632 @default.
• W3118541844 cites W2176932077 @default.
• W3118541844 cites W2320742188 @default.
• W3118541844 cites W2339074459 @default.
• W3118541844 cites W2346739505 @default.
• W3118541844 cites W2543851377 @default.
• W3118541844 cites W2567881168 @default.
• W3118541844 cites W2626915093 @default.
• W3118541844 cites W2765685443 @default.
• W3118541844 cites W2793924342 @default.
• W3118541844 cites W2896570148 @default.
• W3118541844 cites W2910415225 @default.
• W3118541844 cites W2921323686 @default.
• W3118541844 cites W2934927297 @default.
• W3118541844 cites W2980508411 @default.
• W3118541844 cites W3022052974 @default.
• W3118541844 cites W3033604724 @default.
• W3118541844 doi "https://doi.org/10.1007/s12640-021-00329-x" @default.
• W3118541844 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8096775" @default.
• W3118541844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33428180" @default.
• W3118541844 hasPublicationYear "2021" @default.
• W3118541844 type Work @default.
• W3118541844 sameAs 3118541844 @default.
• W3118541844 citedByCount "4" @default.
• W3118541844 countsByYear W31185418442022 @default.
• W3118541844 countsByYear W31185418442023 @default.
• W3118541844 crossrefType "journal-article" @default.
• W3118541844 hasAuthorship W3118541844A5038460349 @default.
• W3118541844 hasAuthorship W3118541844A5061448417 @default.
• W3118541844 hasAuthorship W3118541844A5069959118 @default.
• W3118541844 hasBestOaLocation W31185418441 @default.
• W3118541844 hasConcept C118552586 @default.
• W3118541844 hasConcept C126322002 @default.
• W3118541844 hasConcept C136569192 @default.
• W3118541844 hasConcept C137183658 @default.
• W3118541844 hasConcept C15744967 @default.
• W3118541844 hasConcept C170493617 @default.
• W3118541844 hasConcept C187714386 @default.
• W3118541844 hasConcept C2775864247 @default.
• W3118541844 hasConcept C2778941446 @default.
• W3118541844 hasConcept C2779177272 @default.
• W3118541844 hasConcept C2781001258 @default.
• W3118541844 hasConcept C2781161787 @default.
• W3118541844 hasConcept C35124327 @default.
• W3118541844 hasConcept C37000724 @default.
• W3118541844 hasConcept C42219234 @default.
• W3118541844 hasConcept C48856860 @default.
• W3118541844 hasConcept C513476851 @default.
• W3118541844 hasConcept C71924100 @default.
• W3118541844 hasConcept C98274493 @default.
• W3118541844 hasConceptScore W3118541844C118552586 @default.
• W3118541844 hasConceptScore W3118541844C126322002 @default.
• W3118541844 hasConceptScore W3118541844C136569192 @default.
• W3118541844 hasConceptScore W3118541844C137183658 @default.
• W3118541844 hasConceptScore W3118541844C15744967 @default.
• W3118541844 hasConceptScore W3118541844C170493617 @default.
• W3118541844 hasConceptScore W3118541844C187714386 @default.
• W3118541844 hasConceptScore W3118541844C2775864247 @default.
• W3118541844 hasConceptScore W3118541844C2778941446 @default.
• W3118541844 hasConceptScore W3118541844C2779177272 @default.
• W3118541844 hasConceptScore W3118541844C2781001258 @default.
• W3118541844 hasConceptScore W3118541844C2781161787 @default.
• W3118541844 hasConceptScore W3118541844C35124327 @default.
• W3118541844 hasConceptScore W3118541844C37000724 @default.
• W3118541844 hasConceptScore W3118541844C42219234 @default.
• W3118541844 hasConceptScore W3118541844C48856860 @default.
• W3118541844 hasConceptScore W3118541844C513476851 @default.
• W3118541844 hasConceptScore W3118541844C71924100 @default.
• W3118541844 hasConceptScore W3118541844C98274493 @default.
• W3118541844 hasIssue "3" @default.

• next